Quastella

BiotechnologySeedNagoya-shi, Japanquastella.com

Latest round

Seed

Last raised

Oct 2023

Total raised

Undisclosed

Investors

2

About Quastella

Based in Nagoya, Japan, and founded in 2019, Quastella Inc. provides AI-based solutions to analyze, improve, and standardize the process of cultivating living cells. In October 2023, Quastella Inc. Quastella's flagship product, Cell Culture DX, is a control technology designed to cater to a wide spectrum of industries. It finds application in drug discovery, cosmetics, pesticides, regenerative medicine, cellular agriculture, and more. The product enables users to optimize their cell culture processes, ensuring the highest standards of quality and efficiency. In addition, the company also offers Cytometa, a cell quality control platform designed to enhance the value of cell imaging. By leveraging AI and data-driven insights, Cytometa empowers researchers and professionals to improve the quality and accuracy of cell image analysis.

Who invested in Quastella

2 investors across 1 round

See all investors in Quastella

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Oct 18, 2023

    Amount

    Undisclosed

    Investors

    Locked

Questions about Quastella

Who invested in Quastella?

Quastella has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Quastella raised?

Quastella has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Quastella last raise money?

Quastella's most recent round on record is a Seed, in Oct 2023.

What does Quastella do?

Based in Nagoya, Japan, and founded in 2019, Quastella Inc.

Where is Quastella headquartered?

Quastella is headquartered in Nagoya-shi, Japan.

Which VCs invest in companies like Quastella?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Quastella's stage. Their profiles are linked below.

Raising like Quastella? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.